Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Tanabe

Showing results (721-730 of 759) with videos related to

Pageof 76
Sort By:
Biorxiv : the Preprint Server for Biology|May 3, 2023
Tailored chemical reactivity probes for systemic imaging of aldehydes in fibroproliferative diseasesHua Ma, Iris Y Zhou, Y Iris Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2019
Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall SurvivalNina N Sanford, Jennifer Pursley, Bridget Noe, et al.
Journal of the American Chemical Society|August 17, 2023
Tailored Chemical Reactivity Probes for Systemic Imaging of Aldehydes in Fibroproliferative DiseasesHua Ma, Iris Y Zhou, Y Iris Chen, et al.
Hepatology Communications|July 21, 2018
Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonistDerek J Erstad, Christian T Farrar, Sarani Ghoshal, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanomaR Soiffer, T Lynch, M Mihm, et al.
The Oncologist|August 7, 2015
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic CholangiocarcinomaLipika Goyal, Aparna Govindan, Rahul A Sheth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRIDerek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
Theranostics|September 30, 2024
Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studiesShadi A Esfahani, Hua Ma, Shriya Krishna, et al.
Annals of Surgery|February 21, 2022
Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal CarcinomatosisFelipe S Furtado, Mark Z Wu, Shadi A Esfahani, et al.
Journal of the National Cancer Institute|September 28, 2017
Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor GenotypeTheodore S Hong, Jennifer Y Wo, Darrell R Borger, et al.
Pageof 76

Showing results (721-730 of 759) with videos related to

Sort By:
Pageof 76
Biorxiv : the Preprint Server for Biology|May 3, 2023
Tailored chemical reactivity probes for systemic imaging of aldehydes in fibroproliferative diseasesHua Ma, Iris Y Zhou, Y Iris Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2019
Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall SurvivalNina N Sanford, Jennifer Pursley, Bridget Noe, et al.
Journal of the American Chemical Society|August 17, 2023
Tailored Chemical Reactivity Probes for Systemic Imaging of Aldehydes in Fibroproliferative DiseasesHua Ma, Iris Y Zhou, Y Iris Chen, et al.
Hepatology Communications|July 21, 2018
Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonistDerek J Erstad, Christian T Farrar, Sarani Ghoshal, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanomaR Soiffer, T Lynch, M Mihm, et al.
The Oncologist|August 7, 2015
Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic CholangiocarcinomaLipika Goyal, Aparna Govindan, Rahul A Sheth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2020
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRIDerek J Erstad, Mozhdeh Sojoodi, Martin S Taylor, et al.
Theranostics|September 30, 2024
Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studiesShadi A Esfahani, Hua Ma, Shriya Krishna, et al.
Annals of Surgery|February 21, 2022
Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal CarcinomatosisFelipe S Furtado, Mark Z Wu, Shadi A Esfahani, et al.
Journal of the National Cancer Institute|September 28, 2017
Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor GenotypeTheodore S Hong, Jennifer Y Wo, Darrell R Borger, et al.
Pageof 76